Table 2.
Biosimilars and their respective approved regulatory standards.
| Rituximab biosimilar | Approved regulator standards | Reference |
|---|---|---|
| BCD-020 | Ministry of the Russian Federation, Department of Biotechnology and the Central Drugs Standard Control Organization (under review) | (173, 224) |
| CT-P10 | European Medicines Agency, Korean Ministry of Food and Drug Safety, & FDA (under review) | (225, 226) |
| Maball | Department of Biotechnology and the Central Drugs Standard Control Organization | (227) |
| MabTas | Central Drugs Standard Control Organization | (210) |
| Novex | National Drugs, Foods and Medical Technology Administration (ANMAT) | (228) |
| Reditux | Department of Biotechnology and the Central Drugs Standard Control Organization | (210) |
| Rituxirel | Department of Biotechnology and the Central Drugs Standard Control Organization | (210) |
| Zytux | Food and Drug Organization | (229) |